BrightSpring Health Services, Inc.
BTSG
$17.45
$0.030.17%
| Weiss Ratings | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | E | |||
| Rating Factors | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.17% | |||
| 30-Day Total Return | -26.43% | |||
| 60-Day Total Return | -5.47% | |||
| 90-Day Total Return | 3.81% | |||
| Year to Date Total Return | 0.69% | |||
| 1-Year Total Return | 97.62% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -29.69% | |||
| 52-Week Low % Change | 102.91% | |||
| Price | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $24.82 | |||
| 52-Week Low Price | $8.60 | |||
| 52-Week Low Price (Date) | Mar 18, 2024 | |||
| 52-Week High Price (Date) | Jan 30, 2025 | |||
| Valuation | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.05B | |||
| Enterprise Value | 5.89B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.12 | |||
| Earnings Per Share Growth | -90.68% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.33 | |||
| Price/Book (Q) | 1.85 | |||
| Enterprise Value/Revenue (TTM) | 0.52 | |||
| Price | $17.45 | |||
| Enterprise Value/EBITDA (TTM) | 10.85 | |||
| Enterprise Value/EBIT | 17.40 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 213.16M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 502 394 2100 | |||
| Address | 805 North Whittington Parkway Louisville, KY 40222 | |||
| Website | www.brightspringhealth.com | |||
| Country | United States | |||
| Year Founded | 1974 | |||
| Profitability | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 3.00% | |||
| Profit Margin | -0.16% | |||
| Management Effectiveness | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.69% | |||
| Return on Equity | -- | |||
| Income Statement | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 11.27B | |||
| Total Revenue (TTM) | 11.27B | |||
| Revenue Per Share | $52.85 | |||
| Gross Profit (TTM) | 1.59B | |||
| EBITDA (TTM) | 542.96M | |||
| EBIT (TTM) | 338.47M | |||
| Net Income (TTM) | -18.06M | |||
| Net Income Avl. to Common (TTM) | -18.06M | |||
| Total Revenue Growth (Q YOY) | 28.56% | |||
| Earnings Growth (Q YOY) | 313.91% | |||
| EPS Diluted (TTM) | -0.12 | |||
| EPS Diluted Growth (Q YOY) | 243.06% | |||
| Balance Sheet | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 71.89M | |||
| Cash Per Share (Q) | $0.34 | |||
| Total Current Assets (Q) | 1.89B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.65B | |||
| Current Ratio (Q) | 1.325 | |||
| Book Value Per Share (Q) | $9.46 | |||
| Total Assets (Q) | 5.93B | |||
| Total Current Liabilities (Q) | 1.43B | |||
| Total Debt (Q) | 2.90B | |||
| Total Liabilities (Q) | 4.27B | |||
| Total Common Equity (Q) | 1.65B | |||
| Cash Flow | BTSG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -140.24M | |||
| Cash from Financing (TTM) | 164.65M | |||
| Net Change in Cash (TTM) | 48.18M | |||
| Levered Free Cash Flow (TTM) | 44.71M | |||
| Cash from Operations (TTM) | 23.77M | |||
